GLP-1 Weight Loss in Hong Kong: The Complete Guide (2026)

Obesity rates in Hong Kong have risen sharply over the past decade, with roughly one in three adults classified as overweight or obese(Based on clinical guidelines and prescribing information). For many people, diet and exercise alone are not enough — and that is where GLP-1 receptor agonist medications come in.

GLP-1 (glucagon-like peptide-1) medications represent the most significant advancement in medical weight management in decades. Originally developed for type 2 diabetes, these drugs have been shown to produce substantial, clinically meaningful weight loss in people with and without diabetes.

This guide covers everything you need to know about GLP-1 weight-loss treatment in Hong Kong: how the medications work, what results to expect, costs, side effects, and how to access treatment through noah™.

What Are GLP-1 Receptor Agonists?

GLP-1 receptor agonists are a class of medications that mimic the action of GLP-1, a naturally occurring hormone produced in the gut after eating. GLP-1 plays multiple roles in metabolic regulation:

• Appetite suppression: GLP-1 acts on the hypothalamus to reduce hunger and increase satiety, meaning you feel full faster and stay full longer (Drucker DJ. Cell Metab. 2018;27(4):740-756. PMID: 29617641).
• Slowed gastric emptying: The medication slows the rate at which food leaves your stomach, prolonging the feeling of fullness.
• Insulin regulation: GLP-1 enhances glucose-dependent insulin secretion, helping to stabilise blood sugar levels.
• Glucagon suppression: It reduces glucagon release, which lowers glucose production by the liver.

The net effect is that patients eat less, feel satisfied with smaller portions, and experience fewer cravings — particularly for high-calorie, high-fat foods.

GLP-1 Medications Available in Hong Kong

Several GLP-1 medications are registered with the Hong Kong Department of Health. The three most commonly prescribed for weight management are:

Semaglutide (Ozempic® — Injectable)

Ozempic is a once-weekly subcutaneous injection. While originally approved for type 2 diabetes, semaglutide at a 2.4 mg dose (branded as Wegovy® in some markets) has been extensively studied for weight loss.

In the landmark STEP 1 trial, participants without diabetes who received semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo (Wilding JPH et al. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185).

Semaglutide (Rybelsus® — Oral)

Rybelsus is the oral formulation of semaglutide, taken as a daily tablet. It offers a needle-free alternative for patients who prefer not to self-inject. The oral form has demonstrated weight-loss efficacy, though generally less than the injectable version at equivalent doses(Based on clinical guidelines and prescribing information).

Rybelsus must be taken on an empty stomach with no more than 120 mL of water, and patients must wait at least 30 minutes before eating, drinking, or taking other medications.

Tirzepatide (Mounjaro®)

Tirzepatide is a dual GIP/GLP-1 receptor agonist — meaning it activates both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism has produced the most impressive weight-loss results seen in clinical trials to date.

In the SURMOUNT-1 trial, participants receiving the highest dose of tirzepatide (15 mg) lost an average of 22.5% of their body weight over 72 weeks (Jastreboff AM et al. N Engl J Med. 2022;387(3):205-216. PMID: 35658024).

Liraglutide (Saxenda®)

Liraglutide was the first GLP-1 receptor agonist specifically approved for weight management. It is a daily subcutaneous injection. In the SCALE trial, participants receiving liraglutide 3.0 mg lost an average of 8.0% of their body weight over 56 weeks (Pi-Sunyer X et al. N Engl J Med. 2015;373(1):11-22. PMID: 26132939).

For a detailed comparison, see: Ozempic vs Rybelsus vs Mounjaro: Which GLP-1 Is Right for You?

How Much Weight Can You Lose?

Clinical trial results provide a strong evidence base:

For a 90 kg individual, this translates to approximately: - Semaglutide: ~13.4 kg lost - Tirzepatide: ~20.3 kg lost - Liraglutide: ~7.2 kg lost

Individual results vary based on starting weight, adherence, diet, exercise, and other factors. For more detail, see: How Much Weight Will You Actually Lose on GLP-1? Clinical Data Explained

Side Effects and Safety

GLP-1 medications are generally well-tolerated, but gastrointestinal side effects are common, especially during dose escalation:

• Very common (>10%): Nausea, diarrhoea, constipation
• Common (1-10%): Vomiting, abdominal pain, headache, fatigue
• Uncommon (<1%): Pancreatitis, gallbladder issues

Most GI side effects are mild to moderate and decrease over time as the body adjusts. The gradual dose-escalation schedule (starting low and increasing over weeks) is designed to minimise these effects.

Contraindications include: - Personal or family history of medullary thyroid carcinoma - Multiple endocrine neoplasia syndrome type 2 (MEN 2) - Pregnancy or breastfeeding - Severe gastrointestinal disease

For a complete side-effect guide, see: GLP-1 Side Effects: What to Expect and How to Manage Them

Who Is Eligible?

In Hong Kong, GLP-1 medications for weight management are typically prescribed for individuals who meet the following criteria(Based on clinical guidelines and prescribing information):

• BMI ≥ 27 kg/m² with at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia, type 2 diabetes, obstructive sleep apnoea), OR
• BMI ≥ 30 kg/m² regardless of comorbidities

Note: BMI thresholds may be adjusted for Asian populations, where metabolic risk increases at lower BMI levels. The WHO recommends a lower BMI cut-off of 23 kg/m² for overweight and 25 kg/m² for obesity in Asian populations(Based on clinical guidelines and prescribing information).

A doctor will assess your full medical history, current medications, and health goals before prescribing.

Cost of GLP-1 Treatment in Hong Kong

GLP-1 medications are not covered by the Hospital Authority (HA) formulary for weight management(Based on clinical guidelines and prescribing information). Treatment is available through private healthcare providers.

Approximate monthly costs in Hong Kong:

Costs vary depending on dosage, pharmacy, and whether the medication is sourced locally or imported. noah™ offers transparent pricing with no hidden fees.

For a full cost breakdown, see: How Much Does GLP-1 Weight Loss Treatment Cost in Hong Kong?

How noah™ GLP-1 Treatment Works

noah™ provides a convenient, doctor-led online weight management service in Hong Kong:

1. Online consultation — Complete a health assessment and consult with a licensed Hong Kong doctor via our platform. No clinic visit required.
2. Doctor evaluation — Your doctor reviews your medical history, current medications, BMI, and weight-loss goals to determine if GLP-1 therapy is appropriate for you.
3. Prescription & delivery — If prescribed, your medication is dispensed by a licensed pharmacy and delivered discreetly to your door in Hong Kong.
4. Ongoing support — Regular follow-up consultations to monitor progress, adjust dosing, and manage any side effects.

For more on the consultation process: How Online GLP-1 Consultations Work in Hong Kong

GLP-1 for Men

While weight-loss discussions often focus on women, GLP-1 medications are equally effective for men — and may offer particular benefits for visceral fat reduction.

Men tend to carry excess weight around the abdomen (visceral fat), which is the most metabolically dangerous type of fat. Visceral fat is strongly linked to cardiovascular disease, type 2 diabetes, and metabolic syndrome(Based on clinical guidelines and prescribing information).

Clinical trials show that GLP-1 medications significantly reduce waist circumference and visceral fat in male participants(Based on clinical guidelines and prescribing information).

For more: GLP-1 for Men: Targeting Visceral Fat and Metabolic Health

What Happens When You Stop?

One of the most important questions patients ask: will the weight come back?

Research suggests that weight regain is common after discontinuing GLP-1 medications. In extension studies, participants who stopped semaglutide regained approximately two-thirds of their lost weight within one year(Based on clinical guidelines and prescribing information).

This does not mean treatment is futile — rather, it highlights the importance of: - Long-term treatment planning with your doctor - Building sustainable lifestyle habits during treatment - Gradual dose reduction rather than abrupt cessation

For a full analysis: Weight Rebound After Stopping GLP-1: What the Evidence Shows

Lifestyle and GLP-1: Getting the Best Results

GLP-1 medications work best as part of a comprehensive approach:

• Diet: Focus on protein-rich meals (1.2–1.6 g protein per kg body weight per day) to preserve muscle mass during weight loss(Based on clinical guidelines and prescribing information). Eat slowly and listen to your new satiety signals.
• Exercise: Combine resistance training (to maintain lean mass) with cardiovascular exercise (for metabolic health). Aim for at least 150 minutes of moderate activity per week.
• Sleep: Poor sleep is strongly associated with weight gain and treatment resistance(Based on clinical guidelines and prescribing information). Aim for 7–9 hours nightly.
• Hydration: Drink adequate water, especially given the GI side effects that can cause fluid loss.

Hong Kong Regulatory Context

In Hong Kong, GLP-1 medications are classified as prescription-only medicines under the Pharmacy and Poisons Ordinance (Cap. 138). They must be prescribed by a registered medical practitioner and dispensed by a registered pharmacist(Based on clinical guidelines and prescribing information).

noah™ operates with fully licensed doctors registered with the Medical Council of Hong Kong and works with licensed pharmacies for all dispensing.

Important: Be cautious of unregistered online sellers or parallel-imported medications. Always ensure your GLP-1 medication comes from a legitimate, regulated source.

Frequently Asked Questions

1. Do I need to see a doctor in person for GLP-1 prescriptions in Hong Kong?

No. Telemedicine consultations are permitted in Hong Kong for appropriate conditions(Based on clinical guidelines and prescribing information). noah™ connects you with licensed Hong Kong doctors through our online platform. However, your doctor may recommend in-person follow-up if clinically necessary.

2. Are GLP-1 medications covered by Hong Kong insurance?

Most private medical insurance plans in Hong Kong do not routinely cover GLP-1 medications for weight management(Based on clinical guidelines and prescribing information). Some plans may cover them if prescribed for type 2 diabetes. Check with your insurer directly.

3. How long do I need to take GLP-1 medication?

GLP-1 treatment for weight management is typically long-term. Clinical evidence shows weight regain after discontinuation. Most doctors recommend a minimum of 12–18 months, with ongoing reassessment. Your noah™ doctor will work with you to develop a personalised treatment timeline.

4. Can I take GLP-1 medication if I have type 2 diabetes?

Yes — GLP-1 medications were originally developed for diabetes management and can help with both blood sugar control and weight loss. However, dose adjustments and monitoring of blood glucose are essential. Inform your doctor of all diabetes medications you are taking.

5. Is it safe to take GLP-1 medication long-term?

Long-term safety data for semaglutide and liraglutide extends to several years, with an overall favourable safety profile(Based on clinical guidelines and prescribing information). Tirzepatide long-term data is still being collected. Your doctor will monitor you regularly for any adverse effects.

6. What if I experience severe nausea?

Some nausea during dose escalation is normal. Strategies include eating smaller meals, avoiding fatty or spicy foods, and staying hydrated. If nausea is severe or persistent, your doctor may slow the dose-escalation schedule or adjust your medication.

7. Can I drink alcohol while on GLP-1 medication?

Moderate alcohol consumption is generally acceptable, but alcohol can worsen nausea and may affect blood sugar levels. Discuss your alcohol intake with your doctor.

8. Will GLP-1 medication affect my fertility?

GLP-1 medications are contraindicated during pregnancy. Women of childbearing age should use effective contraception during treatment. Importantly, weight loss can actually improve fertility, so contraception planning is essential(Based on clinical guidelines and prescribing information). Discontinue the medication at least 2 months before planned conception.

9. How quickly will I see results?

Most patients notice appetite reduction within the first 1–2 weeks. Visible weight loss typically begins within 4–8 weeks, with the most significant results seen at 6–12 months of continuous treatment.

10. How do I get started with noah™?

Visit the noah™ website, complete the online health assessment, and book a consultation with a licensed doctor. If GLP-1 therapy is appropriate for you, your prescription will be processed and your medication delivered to your door in Hong Kong.

11. What's the difference between Ozempic and Wegovy?

Both contain semaglutide. Ozempic is approved for type 2 diabetes (doses up to 2.0 mg), while Wegovy is specifically approved for weight management (dose of 2.4 mg). In Hong Kong, availability may vary — your doctor will prescribe the most appropriate option(Based on clinical guidelines and prescribing information).

12. Can I switch between different GLP-1 medications?

Yes, switching is possible under medical supervision. Common reasons include inadequate response, intolerable side effects, or cost considerations. Your doctor will guide the transition, including appropriate dose adjustments.

References

1. Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metab. 2018;27(4):740-756. PMID: 29617641
2. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185
3. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PMID: 35658024
4. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. PMID: 26132939

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any medication. Treatment suitability is determined by your prescribing doctor based on your individual health profile.

© 2026 noah™. All rights reserved.